ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 706,51
0,33%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Genelabs Technologies (MM) (GNLB)

  7. Genelabs Technologies (MM) (GNLB) Actualités

GNLB

Genelabs (GNLB)

Genelabs Technologies (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GNLB
DateHeureSourceTitreSymboleSociété
07/01/200923h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200922h46Edgar (US Regulatory)(25-NSE)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200919h34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200914h59Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200914h50PR Newswire (US)GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
30/12/200814h50PR Newswire (US)GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.NASDAQ:GNLB
15/12/200815h00PR Newswire (US)GlaxoSmithKline Further Extends Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
08/12/200815h11PR Newswire (US)GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
05/12/200816h50Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:GNLBGenelabs Technologies (MM)
03/12/200822h30PR Newswire (US)GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
20/11/200812h00Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200822h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200820h37Business WireGenelabs Reports Results for the Third Quarter and First Nine Months of 2008NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200820h12Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200821h47Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200821h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200818h01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200817h54Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200815h44PR Newswire (US)GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
05/11/200823h30Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:GNLBGenelabs Technologies (MM)
05/11/200823h30Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:GNLBGenelabs Technologies (MM)
04/11/200821h29Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:GNLBGenelabs Technologies (MM)
31/10/200814h00PR Newswire (US)Beacon Equity Issues Technical Trade Alerts on Market Movers: GNLB, SPSN, PDGI, SIMO, UCTT, CYCLNASDAQ:GNLBGenelabs Technologies (MM)
30/10/200821h53Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:GNLBGenelabs Technologies (MM)
30/10/200811h01Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:GNLBGenelabs Technologies (MM)
30/10/200801h44PR Newswire (US)GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis CNASDAQ:GNLBGenelabs Technologies (MM)
09/10/200818h15Business WireGenelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at the 15th International Sym...NASDAQ:GNLBGenelabs Technologies (MM)
07/10/200822h15Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Current report filing (8-K)NASDAQ:GNLBGenelabs Technologies (MM)
03/10/200823h01Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
18/09/200813h23Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Amended Statement of Ownership (SC 13G/A)NASDAQ:GNLBGenelabs Technologies (MM)
 Showing the most relevant articles for your search:NASDAQ:GNLB

Dernières Valeurs Consultées

BIT
P1D9Y9
BNP Paribas Issuance
BIT
P19YE5
BNP Paribas Issuance
BIT
I06601
Intesa Sanpaolo
AQSE
PHP.GB
Primary Health Prop
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés